IRIS
DI IOIA, MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.374
EU - Europa 1.100
AS - Asia 519
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 4
AF - Africa 1
Totale 3.005
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.373
CN - Cina 305
IE - Irlanda 225
IT - Italia 189
UA - Ucraina 179
TR - Turchia 147
GB - Regno Unito 146
SE - Svezia 138
FR - Francia 85
DE - Germania 77
IN - India 49
FI - Finlandia 39
BE - Belgio 11
EU - Europa 7
VN - Vietnam 6
AU - Australia 4
IR - Iran 4
DK - Danimarca 2
GR - Grecia 2
KR - Corea 2
PL - Polonia 2
AM - Armenia 1
CA - Canada 1
EG - Egitto 1
HR - Croazia 1
IL - Israele 1
LU - Lussemburgo 1
MD - Moldavia 1
PH - Filippine 1
PK - Pakistan 1
RO - Romania 1
RU - Federazione Russa 1
SG - Singapore 1
TW - Taiwan 1
Totale 3.005
Salva come PNG Salva come JPEG
Città #
Chandler 288
Jacksonville 251
Dublin 222
Southend 116
Princeton 94
Nanjing 85
Ashburn 81
Ann Arbor 76
Izmir 73
Beijing 69
Chieti 67
Dearborn 62
Wilmington 40
Cambridge 39
New York 34
Altamura 32
Nanchang 29
Woodbridge 18
Washington 16
Grevenbroich 15
Kunming 14
Boardman 13
Shenyang 13
Jiaxing 12
Brussels 11
Guangzhou 11
Hebei 11
Norwalk 11
Tianjin 11
Los Angeles 10
Hangzhou 9
San Mateo 8
Changsha 7
Houston 7
Monmouth Junction 7
Dong Ket 6
Falls Church 6
Jinan 6
Lanzhou 6
London 6
Pescara 5
Roseto Degli Abruzzi 5
Changchun 4
Edinburgh 4
Hanover 4
San Vito Chietino 4
Seattle 4
Teramo 4
Zhengzhou 4
Ardabil 3
Augusta 3
Helsinki 3
La Spezia 3
Milan 3
Mumbai 3
Ningbo 3
Taizhou 3
Tatura 3
Torino 3
Benevento 2
Campodipietra 2
Copenhagen 2
Fairfield 2
Kraków 2
L'aquila 2
Leawood 2
Padova 2
Pianella 2
Redmond 2
Redwood City 2
Tappahannock 2
Verona 2
Andover 1
Anzio 1
Arlington 1
Atlanta 1
Auburn Hills 1
Bangalore 1
Boston 1
Brisbane 1
Cairo 1
Campobasso 1
Candiolo 1
Centrale 1
Chengdu 1
Düsseldorf 1
Frankfurt am Main 1
Genova 1
Hefei 1
Hyderabad 1
Jian 1
Lanciano 1
Manchester 1
Manila 1
Monte di Procida 1
Montesilvano 1
Moscow 1
Mountain View 1
Orange 1
Parrano 1
Totale 2.014
Salva come PNG Salva come JPEG
Nome #
An integrated metabolomics approach for the research of new cerebrospinal fluid biomarkers of multiple sclerosis 129
Enhanced release of acid sphingomyelinase-enriched exosomes generates a lipidomics signature in CSF of Multiple Sclerosis patients 121
Integrated Lipidomics and Metabolomics Analysis of Tears in Multiple Sclerosis: An Insight into Diagnostic Potential of Lacrimal Fluid 103
UNRAVELING THE MOLECULAR REPERTOIRE OF TEARS AS A SOURCE OF BIOMARKERS: BEYOND OCULAR DISEASES 100
Cleavage of cystatin C is not associated with multiple sclerosis 97
Integration of metabolomics and proteomics in multiple sclerosis: from biomarkers discovery to personalized medicine 93
Metabolomic Signature in Sera of Multiple Sclerosis Patients during Pregnancy 91
Lipidomic investigations for the characterization of circulating serum lipids in multiple sclerosis 88
TLC-MALDI-Imaging approach for lipidomics studies in cerebrospinal fluid reveals low levels of sphingomyelin in multiple sclerosis patients 83
Metabolomics analysis of cerebrospinal fluid reveals a distintive biochemical alteration associated with multiple sclerosis. 83
The Kurtzke EDSS rank stability increases 4 years after the onset of multiple sclerosis: results from the MSBase Registry. 82
A lipidomic investigation for the caracterisation of CSF lipid profile in patients with multiple sclerosis 82
The Multiple Sclerosis Knowledge Questionnaire: a self administered instrument for recently diagnosed patients 81
Data of safety in a single-center alemtuzumab treated population 77
Increasing age at disability milestones among MS patients in the MSBase Registry 76
Convulsive status epilepticus due to new encephalic demyelinating lesions in multiple sclerosis 75
Alemtuzumab treatment of multiple sclerosis in real-world clinical practice: A report from a single Italian center 70
OXIDATIVE MODIFICATIONS OF CEREBRAL TRANSTHYRETIN ARE ASSOCIATED WITH MULTIPLE SCLEROSIS 68
Development of methods for lipid extraction from CSF and application of mass spectometry techniques for the characterization of the lipid profile and neurosteroids levels in MS patients 68
Nail loss after teriflunomide treatment: a new potential adverse event 68
Country, Sex, EDSS Change and Therapy Choice Independently Predict Treatment Discontinuation in Multiple Sclerosis and Clinically Isolated Syndrome. 66
Acetylcholine in multiple sclerosis: possible involvement in the modulation of the immune response and in oligodendrocyte recruitment. 66
Anti-JCV serostatus, index value and clinical features in patients affected by multiple sclerosis. 66
Natalizumab treatment in multiple sclerosis patients: a multicenter experience in clinical practice in Italy. 65
Patient adherence to and tolerability of self-administered interferon beta-1a using an electronic autoinjection device: a multicentre, open-label, phase IV study 64
An information aid for newly diagnosed multiple sclerosis patients improves disease knowledge and satisfaction with care. 64
Prevalence of JC virus antibodies in human serum and seroconversion rate with first-generation and second generation ELISA: the novel assay improves specificity andsensitivity to detect anti-JC virus antibodies 63
Neuropsychological testing and quantitative electroencephalography: a search of neurophysiological markers of cognitive decline in multiple sclerosis 62
Mass spectrometry based metabonomics of the cerebrospinalfluid highlights a correlation between polar lipids and carnitines levels in multiple sclerosis patients. 62
JCV-Ab serostatus in MS patients treated with Natalizumab 62
Development and validation of a patient self-assessed questionnaire on satisfaction with communication of the multiple sclerosis diagnosis. 62
Natalizumab-associated PML-IRIS: the Chieti experience. 61
Multiphasic Adem or Multiple Sclerosis? Treatement implications. 60
Treatment discontinuation issues in fingolimod treated patients: the Chieti experience. 59
A difficult pediatric case: ADEM evolving in multiple sclerosis complicated by progressive multifocal leukoencephalopathy after Natalizumab treatment. 56
Guidelines on the clinical use for the detection of neutralizing antibodies (NAbs) to IFN beta in multiple sclerosis therapy: report from the Italian Multiple Sclerosis Study group 53
Neuropsychological testing and event-related potentials: markers of cognitive impairment in patients with multiple sclerosis 53
Proteomic investigations on differential post-translational modification of transthyretin in multiple sclerosis. 53
Progressive multifocal leukoencephalopathy associated with natalizumab in paediatric multiple sclerosis 52
Relation between Pro-inflammatory Cytokines and Acetylcholine Levels in Relapsing-Remitting Multiple Sclerosis Patients 46
Risk-benefit considerations in the treatment of relapsing-remitting multiple sclerosis 45
Spinal cord injury in a patient with multiple sclerosis (MS) with secondary hydromyelia 41
Lipidomics analysis reveals low levels of phosphatidylcholines and sphingomyelins in cerebrospinal fluido f multiple sclerosis patients. 37
Simultaneous early-onset severe autoimmune hemolytic anemia and albuminuria during alemtuzumab treatment for multiple sclerosis 37
Contribution of metabolomics to multiple sclerosis diagnosis, prognosis and treatment 29
Totale 3.119
Salva come PNG Salva come JPEG
Categoria #
all - tutte 9.754
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.754
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019107 0 0 0 0 0 0 0 0 0 0 2 105
2019/2020649 171 42 9 5 44 51 81 59 25 79 68 15
2020/2021283 46 3 59 3 5 52 5 0 41 25 30 14
2021/2022232 4 4 9 42 9 13 10 20 16 9 24 72
2022/2023757 61 109 43 74 93 133 34 54 104 15 24 13
2023/2024348 17 18 33 6 30 181 48 5 1 8 1 0
Totale 3.119